Is Smruthi Organics a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Smruthi Organics Ltd is a average quality company .

Is Smruthi Organics undervalued or overvalued?

The key valuation ratios of Smruthi Organics Ltd's currently when compared to its past seem to suggest it is in the Fair zone .

What is Smruthi Organics share price return in the past 10 years?

Data is not available for this company

Is Smruthi Organics a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Smruthi Organics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

Smruthi Organics Ltd - Stock Valuation and Financial Performance

Name: Smruthi Organics
Brand: Smruthi Organics

BSE: 540686 | NSE: | Pharmaceuticals & Drugs | Small Cap

Place order

Smruthi Organics Share Price

₹117.85 -0.10 -0.08%
as on 21-Nov'24 16:59

10 Year X-Ray of Smruthi Organics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	-0%	9.5%	10.6%	-1%	21.5%	25%	39.1%	21%	7.4%	8.2%	-
Value Creation Index ⓘ	-1.0	-0.3	-0.2	-1.1	0.5	0.8	1.8	0.5	-0.5	-0.4	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	76.6	73.8	79.4	97.3	137	131	127	133	141	128	120
Sales YoY Gr.	-	-3.6%	7.6%	22.7%	41.2%	-4.6%	-3.5%	5.4%	5.8%	-9.5%	-
Adj EPS ⓘ	-3.4	0.6	1.4	-2.8	6	5.3	14.9	9.2	3.7	3.3	-0.8
YoY Gr.	-	NA	126.2%	-303.6%	NA	-12.3%	183.5%	-38%	-60.1%	-11.9%	-
BVPS (₹) ⓘ	25.7	26.8	28.2	25.4	31.8	37.1	52.9	58.7	59.6	60.8	60
Adj Net Profit ⓘ	-3.8	0.7	1.6	-3.2	6.9	6	17.1	10.6	4.2	3.7	-1
Cash Flow from Ops. ⓘ	8.5	14	9.2	5.1	12.1	21.4	22.8	2.2	12.1	4.4	-
Debt/CF from Ops. ⓘ	5.2	2.6	3.5	6	2.3	0.7	0.4	1.3	0.5	2.7	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5.8%	-1.5%	0.3%	-9.5%
Adj EPS ⓘ	NA	-11.5%	-39.8%	-11.9%
BVPSⓘ	10%	13.9%	4.8%	2.1%
Share Price	-	23.3%	-21.8%	-40.1%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	-11.9	2.3	5	-10.5	21	15.3	33.1	16.6	6.2	5.4	-1.3
Op. Profit Mgn % ⓘ	6.1	14.4	12.6	3.4	12.5	12.1	22.6	14	7	9.5	5.2
Net Profit Mgn % ⓘ	-5	1	2	-3.3	5	4.6	13.5	7.9	3	2.9	-0.8
Debt to Equity ⓘ	1.5	1.2	1	1.1	0.8	0.4	0.2	0	0.1	0.2	0.1
Working Cap Days ⓘ	334	317	258	194	155	163	139	132	153	197	89
Cash Conv. Cycle ⓘ	93	99	90	80	66	58	48	81	92	99	42

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years 0.30%

Sales growth is not so good in last 4 quarters at -10.29%

Latest Financials - Smruthi Organics Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0.8	-
TTM Sales (₹ Cr.)	120	-
BVPS (₹.) ⓘ	60	-
Reserves (₹ Cr.) ⓘ	57	-
P/BV ⓘ	1.97	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	115.30 / 218.80
All Time Low / High (₹)	21.70 / 419.35
Market Cap (₹ Cr.)	135
Equity (₹ Cr.)	11.5
Face Value (₹)	10
Industry PE ⓘ	43

Management X-Ray of Smruthi Organics:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Smruthi Organics

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Smruthi Organics

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	77	74	79	97	137	131	127	133	141	128
Operating Expenses ⓘ	72	63	69	94	121	116	98	115	131	116
Manufacturing Costs	7	8	9	11	13	14	12	16	18	19
Material Costs	53	43	49	61	91	83	66	80	91	72
Employee Cost	6	7	8	9	13	14	12	14	16	17
Other Costs ⓘ	5	5	3	13	4	5	8	5	6	7
Operating Profit ⓘ	5	11	10	3	17	15	29	18	10	12
Operating Profit Margin (%)	6.1%	14.4%	12.5%	3.3%	12.1%	11.6%	22.6%	13.8%	6.9%	9.4%
Other Income ⓘ	0	0	1	0	1	4	1	1	0	0
Interest ⓘ	6	5	4	4	4	3	1	1	1	1
Depreciation ⓘ	5	4	4	4	4	4	4	4	5	6
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-6	2	3	-5	10	12	24	14	4	5
Tax ⓘ	-2	1	1	-1	3	4	7	3	0	1
Profit After Tax	-4	1	2	-3	7	8	17	10	4	4
PAT Margin (%)	-5.0%	1.0%	2.0%	-3.3%	5.0%	6.4%	13.5%	7.8%	2.9%	2.8%
Adjusted EPS (₹)	-3.3	0.6	1.4	-2.8	6.0	7.4	15.0	9.1	3.6	3.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	11%	14%	20%	33%	55%	48%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	29	31	32	29	36	42	60	67	68	70
Share Capital ⓘ	4	4	4	4	4	4	11	11	11	11
Reserves ⓘ	26	27	28	25	33	39	49	56	57	58
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	40	31	27	29	28	16	10	3	5	10
Long Term Debt	17	14	8	6	2	2	1	0	1	6
Short Term Debt	23	17	19	23	25	14	10	3	5	4
Trade Payables	15	15	17	22	30	22	14	11	25	29
Others Liabilities ⓘ	22	26	10	4	7	7	7	7	9	11
Total Liabilities ⓘ	107	102	85	84	101	88	92	88	107	119
Fixed Assets
Gross Block	87	88	30	94	98	104	107	114	122	131
Accumulated Depreciation	52	56	0	64	68	72	76	81	85	91
Net Fixed Assetsⓘ	35	32	30	30	30	32	31	33	37	40
CWIP ⓘ	1	1	1	1	2	0	1	1	2	1
Investmentsⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	18	19	19	21	23	17	18	20	24	30
Trade Receivables	22	19	21	25	36	25	21	28	37	41
Cash Equivalents	2	2	2	2	4	4	16	1	2	1
Others Assetsⓘ	30	29	12	5	6	11	4	4	5	6
Total Assets ⓘ	107	102	85	84	101	88	92	88	107	119

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	9	14	9	5	12	21	23	2	12	4
PBT ⓘ	-6	2	3	-5	10	12	24	14	5	5
Adjustment ⓘ	10	8	7	7	7	7	4	5	5	6
Changes in Working Capital ⓘ	4	4	-1	3	-5	5	0	-13	3	-6
Tax Paid ⓘ	0	0	0	0	0	-3	-6	-4	-1	-1
Cash Flow From Investing Activity ⓘ	-1	0	0	-3	-4	-5	-3	7	-10	-7
Capex	-1	-1	-2	-4	-5	-5	-4	-7	-9	-8
Net Investments	0	0	0	0	0	0	0	13	-1	1
Others ⓘ	0	1	1	1	0	0	1	1	0	0
Cash Flow From Financing Activityⓘ	-8	-14	-9	-2	-5	-17	-7	-12	-2	3
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	4	-4	-4	-2	-4	0	0	0	1	6
Interest Paid ⓘ	-6	-5	-4	-4	-4	-3	-1	-1	-1	-1
Dividend Paid ⓘ	0	0	0	0	0	-2	0	-3	-3	-2
Others ⓘ	-6	-5	0	4	2	-12	-5	-7	2	-1
Net Cash Flow ⓘ	-1	0	0	0	2	-1	13	-3	0	0

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	-11.83	2.41	5.03	-10.48	20.97	21.43	33.23	16.27	6.11	5.21
ROCE (%)	-0.01	9.53	10.6	-0.96	21.54	25	39.08	21	7.39	8.22
Asset Turnover Ratio	0.7	0.75	0.91	1.16	1.49	1.39	1.41	1.49	1.46	1.17
PAT to CFO Conversion(x)	N/A	14	4.5	N/A	1.71	2.63	1.35	0.2	3	1
Working Capital Days
Receivable Days	106	95	86	86	82	85	66	68	84	108
Inventory Days	94	86	83	75	58	55	51	52	57	74
Payable Days	134	130	117	114	104	114	99	57	71	134

Smruthi Organics Ltd Stock News

Smruthi Organics Ltd FAQs

What is the share price of Smruthi Organics?

Company share prices are keep on changing according to the market conditions. The closing price of Smruthi Organics on 21-Nov-2024 16:59 is ₹117.8.

What is the market cap of Smruthi Organics?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Nov-2024 16:59 the market cap of Smruthi Organics stood at ₹135.0.

What is the P/E ratio of Smruthi Organics?

The latest P/E ratio of Smruthi Organics as of 21-Nov-2024 16:59 is 0.00.

What is the P/B ratio of Smruthi Organics?

The latest P/B ratio of Smruthi Organics as of 21-Nov-2024 16:59 is 1.97.

What is the 52-week high and low of Smruthi Organics?

The 52-week high of Smruthi Organics is ₹218.8 and the 52-week low is ₹115.3.

What is the TTM revenue of Smruthi Organics?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Smruthi Organics is ₹119.8 ( Cr.) .

About Smruthi Organics Ltd

Smruthi Organics Ltd is a mid-size, public limited, API manufacturing company from Solapur, India. Smruthi Organics Ltd was established in1989 by qualified technocrats and has very good experience and reputation in the pharmaceutical industry for the supply of quality products.

Their core competency is multi-step organic synthesis and large scale manufacturing of organic molecules. Their focus has always been API for the regulated markets. They have been part of successful contract manufacturing and custom synthesis agreements with leading European, American and Japanese customers. They are currently expanding our R&D to become a one-stop solution provider from concept to execution for all API including, but not restricted to, the following:

Process Development
Process Optimization
Process Validation
Analytical Methods Validation
Regulatory Support and DMF Registrations
Commercial Manufacturing

Their constant endeavor to improve operations and systems has contributed to our growth. they encourage operational transparency with customers, which complements to confidence building for stronger relationships. Customer satisfaction is their highest priority and they constantly strive on optimizing delivery times of all their services.

Smruthi Organics Ltd facility is USFDA approved and European GMP certified for Carbidopa, Metformin HCL and Norfloxacin. It has successfully filed 4 European and US drug master files for different products.

Smruthi can manage a potential molecule's entire development life cycle up to commercialization through rigorous planning and proper execution. Smruthi can independently or in conjunction with the customer develop optimized synthesis process, perform scale-up and process validations, compile DMF and provide the customer with regulatory support for finished formulation dossier registration. The engagement can be either on an FTE or deliverables basis. We respect absolute confidentiality in such sensitive relationships enhancing smooth exchange of information.

Product range of the company includes:

API